ResearcherUniversitätsklinikum AachenActive in the last 2 years
Edgar Dahl
Matched on ORCID iD 0000-0002-8439-7994; OpenAlex author ID A5042448145. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 4
- Preclinical pancreatic cancer mouse models for treatment with small molecule inhibitors: a systematic review and meta-analysis. Co-author DOI 10.1038/s41598-025-25191-1↗
- Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. Co-author DOI 10.1038/s41598-025-94362-x↗
- ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration. Last author DOI 10.1002/1878-0261.13609↗
- Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Last author DOI 10.3390/cancers15030683↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sophia Villwock · 3 shared papers, 2023–2025 · strength 0.73
- Paper Preclinical pancreatic cancer mouse models for treatment with small molecule inhibitors: a systematic review and meta-a… DOI 10.1038/s41598-025-25191-1↗
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609↗
- Lara Rosaline Heij · 3 shared papers, 2023–2025 · strength 0.55
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683↗
- Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609↗
- Julia Steitz · 1 shared paper, 2025 · strength 0.37
- Maximilian Hauschulz · 2 shared papers, 2023–2024 · strength 0.36
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609↗
- Jennifer R. Kosinski · 2 shared papers, 2023–2024 · strength 0.36
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609↗
- Xiuxiang Tan · 1 shared paper, 2025 · strength 0.19
- Evelien J.M. de Jong · 1 shared paper, 2025 · strength 0.19
- Michail Doukas · 1 shared paper, 2025 · strength 0.19
- Bas Groot Koerkamp · 1 shared paper, 2025 · strength 0.19
- Georg J. Wiltberger · 1 shared paper, 2025 · strength 0.19
- Wolfram Trudo Knoefel · 1 shared paper, 2025 · strength 0.19
- Judith de Vos‐Geelen · 1 shared paper, 2025 · strength 0.19
- Casper H.J. van Eijck · 1 shared paper, 2025 · strength 0.19
- Tom Luedde · 1 shared paper, 2025 · strength 0.19
- Shivan Sivakumar · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.